510(k) Report

510(k) · Cleared

Cleared

Elecsys Cortisol III

K242505510(k) TraditionalCleared Jul 17, 2025329-day reviewClass II21 CFR 862.1205

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Roche Diagnostics · JFT Fluorometric, Cortisol

Cleared on Jul 17, 2025 as substantially equivalent to K062204 (Seradyn, Inc., 2006) after a 329-day review. Its family tree reaches back 2 generations to 2004.

Decided
Jul 17, 2025
Review
329 days
Class
Class II
Product code
JFT
Recalls
None
Predicates
1

Its longest line of descent runs back 2 generations to K033731 (2004). No later device cites it as a predicate yet.

  1. Root · 2 generations backK033731 Axsym Cortisol AssayFujirebio Diagnostics,Inc. · 2004
  2. 1 generation backK062204 Architect Cortisol AssaySeradyn, Inc. · 2006
  3. This deviceK242505 Elecsys Cortisol IIIRoche Diagnostics · 2025
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−2K033731Axsym Cortisol AssayFujirebio Diagnostics,Inc.2004—
−1K062204Architect Cortisol AssaySeradyn, Inc.2006—
0 (this device)K242505Elecsys Cortisol IIIRoche Diagnostics2025—
FIG. 1 — Lineage of K242505, 2004–2025Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in JFT? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

  • Candidate predicates for a device like this, rankedin the report
  • Recall history across each candidate’s familyin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K062204Architect Cortisol Assay
Summary page 6
…Page 1 510k Summary Elecsys Cortisol III (K242505) Predicate Device: ARCHITECT Cortisol (K062204) Establishment Roche Diagnostics GmbH Mannheim, Germany: 9610126 Registration Roche Diagnostics GmbH Penzberg, Ge…
Seradyn, Inc.2006—

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 21 years and passes through 3 companies; a new generation was cleared every 18.8 years on median.
  • None of the 2 ancestors has a recall.

How does its category compare?

All JFT devices

JFT Fluorometric, Cortisol: FDA decisions, review times, recalls and adverse event reports over 20 years. 2025, this device’s year, is highlighted.

FDA decisions per year · JFT

1in 2025

2015: 12016: 12019: 12025: 1
2007high 1 (2015) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · JFT

Too few JFT 510(k)s in any year since 2007 to give a median.

Recalls per year · JFT

1in 2012

2012: 1
2007high 1 (2012) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · JFT

9in 2025

2011: 12012: 162013: 62016: 22017: 42018: 32019: 62020: 42021: 22022: 22023: 92024: 52025: 9
2007high 16 (2012) · low 0 (2007)2025

MAUDE reports naming product code JFT, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—00
20090—00
20100—00
20110—01
20120—116
20130—06
20140—00
20151—00
20161—02
20170—04
20180—03
20191—06
20200—04
20210—02
20220—02
20230—09
20240—05
20251—09
20260—0—

What is it indicated for?

Immunoassay for the in vitro quantitative determination of cortisol in human urine. The determination of cortisol is used for the recognition and treatment of functional disorders of the adrenal gland.

The electrochemiluminescence immunoassay “ECLIA” is intended for use on cobas e immunoassay analyzers.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K242505: Elecsys Cortisol III.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K242505

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026